WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time), in San Francisco, California.
To access the live webcast of the presentation and following breakout session please visit the Investors section of the AMAG website at www.amagpharma.com. A replay of the presentation will be archived on the AMAG website until February 9, 2019.
About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact:
Christi Waarich
781-697-0308
